Medical Communications

Johnson & Johnson has been forced to pay out $70 million after it was alleged that years of using the …

Researchers from Northwestern Medicine and the Rehabilitation Institute of Chicago (RIC) have pinpointed, for the first time, exactly which region …

Adents, a French software developer for unique production identification and ‘Track & Trace’ solutions, and Microsoft have developed, with an …

Sanofi has teamed up with Brazilian research institute Fiocruz to accelerate development of a zika vaccine.This is another step in …

Teva Pharmaceuticals and IBM have announced a partnership that will use IBM Watson Health Cloud with the aim of finding …

Warwickshire-based biotech Mercia Technologies has injected a further £1 million into synthetic biology- specialist Oxford Genetics, bringing their total investment …

AstraZeneca has revealed new results from a Phase III trial investigating the efficacy of its Lynparza drug as a monotherapy …

Mylan’s recent EpiPen price inflation scandal has reignited a seemingly never-ending debate on the power of drug companies to charge …

The latest issue of Pharmafocus is now live and ready to be read! We’ve taken the opportunity to cover some of …

This week has seen a few big collaboration and partnerships occur, whilst there have been some major movements within immunotherapy …

Debiopharm International, the Swiss-based global biopharmaceutical group of five companies, announced that it would be entering into an agreement with …

Gilead Sciences has announced positive results from three Phase II studies upon their drug GS-4997, otherwise known as selonsertib. The …

The Department Health announced that it wanted to reduce the £2.8 billion a year funding for pharmacies by 7%, leading …

The FDA’s advisory committee ruled, in a 14-4 vote, that Allergan’s experimental nocturnal urination medication, SER120, in favour of the …

Eli Lilly received the positive news that their drug, Lartruvo, has been granted accelerated approval for use in conjunction with …